CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Windsor-Essex County Health Unit

The Windsor-Essex County Health Unit provides public health services to the residents and businesses of Windsor and Essex County in Ontario, Canada.

RightCHOICE Benefit Administrators

RightCHOICE Benefit Administrators is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Athena Diagnostics, Inc.

Athena Diagnostics, Inc. is a commercial diagnostic laboratory focused on performing esoteric tests, which the Company refers to as assays, primarily in the field of neurology.

Intivia

Intivia is a Piscataway, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NetMD Business

NetMD Business is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.